首页> 外文期刊>Amino acids >Inhibition of antigen-specific immune responses by co-application of an indoleamine 2,3-dioxygenase (IDO)-encoding vector requires antigen transgene expression focused on dendritic cells
【24h】

Inhibition of antigen-specific immune responses by co-application of an indoleamine 2,3-dioxygenase (IDO)-encoding vector requires antigen transgene expression focused on dendritic cells

机译:通过共同施用吲哚胺2,3-二恶英酶(IDO)编码载体的抑制抗原特异性免疫应答需要抗原转基因表达,其集成在树突细胞上

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

We have previously shown that particle-mediated epidermal delivery (PMED) of plasmids encoding beta-galactosidase (beta Gal) under control of the fascin-1 promoter (pFascin-beta Gal) yielded selective production of the protein in skin dendritic cells (DCs), and suppressed Th2 responses in a mouse model of type I allergy by inducing Th1/Tc1 cells. However, intranasal challenge of mice immunized with pFascin-beta Gal induced airway hyperreactivity (AHR) and neutrophilic inflammation in the lung. The tryptophan-catabolizing enzyme indoleamine 2,3-dioxygenase (IDO) has been implicated in immune suppression and tolerance induction. Here we investigated the consequences of co-application of an IDO-encoding vector on the modulatory effect of DNA vaccination by PMED using pFascin-beta Gal in models of eosinophilic allergic and non-eosinophilic intrinsic airway inflammation. IDO-encoding plasmids and pFascin-beta Gal or pCMV-beta Gal were co-applied to abdominal skin of BALB/c mice without, before or after sensitization with beta Gal protein. Immune responses in the lung were analysed after intranasal provocation and airway reactivity was determined by whole body plethysmography. Co-application of pCMV-IDO with pFascin-beta Gal, but not pCMV-beta Gal inhibited the Th1/Tc1 immune response after PMED. Moreover, AHR in those mice was attenuated following intranasal challenge. Therapeutic vaccination of beta Gal-sensitized mice with pFascin-beta Gal plus pCMV-IDO slightly suppressed airway inflammation and AHR after provocation with beta Gal protein, while prophylactic vaccination was not effective. Altogether, our data suggest that only the combination of DC-restricted antigen and ubiquitous IDO expression attenuated asthma responses in mice, most probably by forming a tryptophan-depleted and kynurenine-enriched micromilieu known to affect neutrophils and T cells.
机译:我们之前已经表明,在对Fascin-1启动子(Pfascin-Beta Gal)的控制下编码β-半乳糖苷酶(Beta Gal)的质粒的粒子介导的表皮递送(PMED)在皮肤树突细胞(DCS)中,选择性地生产蛋白质并且通过诱导TH / TC1细胞抑制I型过敏的小鼠模型中的TH2响应。然而,用pfascin-beta gal诱导的气道高反应性(AHR)和肺中嗜中性炎症免疫的小鼠的鼻内挑战。色氨酸 - 分类酶吲哚胺2,3-二氧化根果(IDO)涉及免疫抑制和耐受诱导。在这里,我们研究了使用嗜酸性过敏和非嗜酸性非嗜酸性内在气道炎症模型的PMACKβGAL对DNA疫苗接种对DNA疫苗接种的调节作用的影响。编码质粒和PFASCIN-BETA GAL或PCMV-Beta GAL与BALB / C小鼠的腹部皮肤共同应用于βGAL蛋白的敏化之前或之后。通过全身体积描绘测定鼻内挑衅和气道反应性后,分析肺中免疫应答。 PCMV-IDO与PFASCIN-BETA GAL的共同施用,但不是PCMV-βGAL抑制PMME后的TH / TC1免疫应答。此外,在鼻内挑战之后,这些小鼠中的AHR衰减。用pfascin-beta gal加上pCmV-Ido的βGAL敏化小鼠的治疗疫苗接种PCMV-IDO略微抑制了βGAL蛋白探测后的气道炎症和AHR,而预防性疫苗接种无效。完全,我们的数据表明,只有DC限制抗原和普遍存在的IDO表达的组合衰减小鼠的哮喘反应,最可能是通过形成含有影响中性粒细胞和T细胞的色氨酸耗尽和犬核苷酸富含的微灯来。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号